X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (681) 681
5-year survivors (619) 619
male (488) 488
female (480) 480
oncology (424) 424
adult (321) 321
middle aged (284) 284
adolescent (281) 281
child (278) 278
cancer (275) 275
risk factors (258) 258
aged (214) 214
mortality (174) 174
long-term survivors (169) 169
late mortality (168) 168
child, preschool (165) 165
young adult (162) 162
survivors (157) 157
children (156) 156
chemotherapy (153) 153
follow-up studies (152) 152
risk (150) 150
pediatrics (141) 141
retrospective studies (130) 130
surgery (129) 129
childhood-cancer (128) 128
research (118) 118
prognosis (117) 117
treatment outcome (117) 117
infant (116) 116
incidence (112) 112
aged, 80 and over (108) 108
survival rate (103) 103
care and treatment (102) 102
health aspects (100) 100
follow-up (98) 98
abridged index medicus (97) 97
hematology (97) 97
radiotherapy (97) 97
cohort studies (96) 96
acute lymphoblastic-leukemia (95) 95
survival (95) 95
time factors (94) 94
analysis (93) 93
adult survivors (92) 92
neoplasms - therapy (85) 85
risk-factors (84) 84
survival analysis (84) 84
cancer in children (83) 83
medicine & public health (83) 83
survivors - statistics & numerical data (82) 82
breast-cancer (81) 81
cancer survivors (80) 80
neoplasms, second primary - epidemiology (78) 78
neoplasms (76) 76
radiation (75) 75
infant, newborn (74) 74
adolescent cancer (73) 73
diagnosis (71) 71
risk assessment (71) 71
long-term survival (70) 70
childhood cancer (69) 69
late effects (68) 68
2nd malignant neoplasms (66) 66
tumors (66) 66
age factors (64) 64
neoplasms - mortality (62) 62
hodgkins-disease (59) 59
outcomes (59) 59
health risk assessment (58) 58
leukemia (57) 57
medicine, general & internal (57) 57
neoplasm staging (56) 56
pancreatic neoplasms - surgery (56) 56
therapy (56) 56
oncology, experimental (55) 55
5-year survival (54) 54
pancreatic neoplasms - mortality (53) 53
pancreaticoduodenectomy (53) 53
population (53) 53
proportional hazards models (53) 53
quality of life (53) 53
cancer therapies (52) 52
epidemiology (51) 51
pancreatic cancer (50) 50
disease (49) 49
neoplasms - epidemiology (49) 49
prevalence (49) 49
quality-of-life (49) 49
united states - epidemiology (49) 49
pancreatic neoplasms - pathology (48) 48
radiotherapy - adverse effects (48) 48
patient outcomes (47) 47
5-year follow-up (46) 46
age (46) 46
antineoplastic agents - adverse effects (46) 46
multivariate analysis (46) 46
neoplasms, second primary - etiology (46) 46
patients (45) 45
registries (43) 43
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cancer, ISSN 0008-543X, 07/2017, Volume 123, Issue 13, pp. 2551 - 2560
BACKGROUND Ewing sarcoma survivors (ESSs) are at increased risk for treatment‐related complications... 
late mortality | Ewing sarcoma | treatment‐related complications | childhood cancer survivors | chronic health conditions | treatment-related complications | STANDARD CHEMOTHERAPY | LONG-TERM SURVIVORS | 5-YEAR SURVIVORS | CARDIOTOXICITY | ACUTE MYELOID-LEUKEMIA | TUMORS | CHILDREN | 2ND MALIGNANCIES | ONCOLOGY | COHORT | Bone Neoplasms - mortality | Bone Neoplasms - therapy | Follow-Up Studies | Sarcoma, Ewing - therapy | Humans | Leukemia, Myeloid, Acute - epidemiology | Middle Aged | Thyroid Neoplasms - epidemiology | Bone Neoplasms - epidemiology | Male | Antineoplastic Agents - therapeutic use | Sarcoma, Ewing - mortality | Neoplasm Recurrence, Local - mortality | Young Adult | Osteosarcoma - epidemiology | Heart Diseases - epidemiology | Orthopedic Procedures | Adult | Female | Retrospective Studies | Child | Breast Neoplasms - epidemiology | Mortality | Survivors | Radiotherapy | Neoplasms, Second Primary - epidemiology | Musculoskeletal Diseases - epidemiology | Adolescent | Anthracyclines - therapeutic use | Chronic Disease | Longitudinal Studies | Cohort Studies | Usage | Chemotherapy | Care and treatment | Cardiomyopathy | Heart diseases | Ewing's sarcoma | Cancer | Therapy | Terminology | Leukemia | Risk | Neoplasms | Incidence | Confidence intervals | Biomedical materials | Osteosarcoma | Aging | Biocompatibility | Children | Chronic illnesses | Thyroid | Sarcoma | Complications | Myeloid leukemia | Health risks | Breast cancer | Survival | Morbidity | Chronic conditions | Thyroid cancer | Acute myeloid leukemia | Tumors
Journal Article
Journal Article
Journal of clinical oncology, ISSN 1527-7755, 2012, Volume 30, Issue 13, pp. 1429 - 1437
Journal Article
Journal Article